Delegation from Binhai New Area Hospital of Traditional Chinese Medicine (Tianjin) Visits Tianjin University of Science & Technology for Exchange Symposium

On July 17, a delegation from ‌Binhai New Area Hospital of Traditional Chinese Medicine (Tianjin)‌ visited Tianjin University of Science & Technology for an in-depth exchange symposium. University leaders, relevant officials and faculty representatives from the College of Biotechnology attended the meeting, which was hosted by ‌Hua Sun‌, Vice Dean of the College of Biotechnology.

‌Lu Fu-Ping ‌, Deputy Party Secretary and President of Tianjin University of Science & Technology, extended a warm welcome to the visiting delegation. He noted that the university has long been dedicated to R&D in fields including biomedicine, medicine-food homologous resources, food for special medical purposes (FSMP) and precision nutrition, with abundant research achievements and a solid foundation for industrial transformation. Currently, the university is actively promoting the deep integration of the biomedical innovation chain and industrial chain. He expressed expectations that the two sides will jointly explore the "Medicine + Engineering" talent cultivation model, advance in-depth integration of industry, academia, research and application, precisely align with the demands of the biomedicine and general health industries in Binhai New Area and the Beijing-Tianjin-Hebei region, and focus on cultivating high-level interdisciplinary talents.

‌Wang Bao-He, Executive President of Binhai New Area Hospital of Traditional Chinese Medicine, thanked the university for its warm reception. He introduced the hospital's historical evolution and current development status, and put forward targeted cooperation directions for both sides based on clinical practice. He looked forward to the organic integration of traditional Chinese medicine (TCM) and the general health sector, systematically exploring the intervention value of medicine-food homologous compound formulas in "preventive treatment of disease" to break through the treatment bottlenecks of four major chronic diseases and age-related degenerative diseases. In the field of wound repair, the hospital urgently hopes to leverage the college's scientific research advantages to jointly carry out R&D on novel external materials made from TCM compound formulas.

‌Jiang Hui-Feng ‌, Dean of the College of Biotechnology, systematically introduced the college's cutting-edge breakthroughs in synthetic biology, especially the key progress in analyzing the biosynthetic pathways of active ingredients in TCM and developing substitutes for rare medicinal herbs. He pointed out that synthetic biology technology provides a brand-new solution to break the bottlenecks in the standardization and modernization of TCM, and expected both sides to strengthen scientific research collaboration in areas such as active ingredient preparation and pharmacodynamic mechanism research, to jointly promote interdisciplinary innovation.

During the exchange session, Vice Dean Sun Hua further detailed the college's scientific research platform development and strong capabilities in research achievement transformation. She stated that the college has profound accumulation in TCM pharmacology, taste improvement of hospital-prepared TCM preparations, and development of medicine-food homologous products, which can provide robust technical support for the clinical transformation of TCM and general health products. In addition, the two sides held heated discussions on TCM fermentation, development of FSMP and special dietary foods, and personalized precision nutrition plans, and reached preliminary cooperation consensus on jointly applying for scientific research projects, building an industry-education integration training base, and carrying out joint talent cultivation. In the future, the two sides will continue to give full play to their respective technical and clinical advantages, take medicine-food homology and precision nutrition as featured directions, and collaboratively support the inheritance and innovation of TCM and the high-quality development of the biomedical industry.